Study time point | Study arm | n | Infection prevalence | ||
---|---|---|---|---|---|
Prevalence (95% CI) | Adjusted RRa (95% CI) | P-value | |||
Follow-up 1 | Intervention | 584 | 15.4 (8.8–22.3) | 1.28 (0.77–2.14) | 0.341 |
Control | 689 | 10.2 (4.7–14.2) | |||
Follow-up 2 | Intervention | 552 | 16.5 (11.8–20.8) | 1.26 (0.83–1.94) | 0.277 |
Control | 624 | 11.2 (7.7–14.8) | |||
Follow-up 3 | Intervention | 531 | 19.6 (12.5–24.4) | 1.38 (0.91–2.10) | 0.124 |
Control | 609 | 11.7 (7.2–16.0) | |||
Follow-up 4 | Intervention | 553 | 17.4 (12.9–21.6) | 1.05 (0.72–1.54) | 0.787 |
Control | 623 | 14.0 (10.3–18.0) |